Publication: 4757

Publication: 4757

Final Results from PRESTO: A Phase 3 Open-Label Study of Combined Androgen Blockade in Patients (pts) with High-Risk Biochemically Relapsed Prostate Cancer (BRPC) (AFT-19)

Google Scholar

Citation:

Meeting Instance:: ESMO 2025
Year:: 2025
Type:: Abstract
Sub type:: Oral
Funding:: AFT
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: JNJ
Grants:: AFT

Corr. Author:
Authors:: Rahul Aggarwal David W. Hillman Han Xiao Joel Picus Paul Corn Mary-Ellen Taplin Tanya Dorff Leonard Appleman Douglas Weckstein Akash Patnaik Alan Bryce Daniel Shevrin James Mohler Katharine Dooley Patrick O'Brien Alan Tan Karla Ballman Ronald C. Chen Scott E. Eggener Michael J. Morris

Networks:: CA043, CA824, IL018, KANSAS, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, LAPS-TN008, LAPS-TX035, NH038

Study: AFT-19
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: